Trial NCT01264770

View at ClinicalTrials.gov 
Org. Study IDs: D4300C00004
Secondary IDs: 2010-023692-26

Last trial update was posted on 2014-05-06

MeSH Interventions

Adalimumab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID